Health Catalyst (HCAT) Stock Forecast & Price Target

$7.61

+0.43 (+5.99%)

(As of 12/1/2023 ET)

Today's Range: $7.13
▼
$7.67
50-Day Range: $6.71
▼
$10.16
52-Week Range: $6.60
▼
$15.87

Volume: 848,951 shs
Average Volume: 482,745 shs
Market Capitalization: $437.96 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $13.40

Health Catalyst Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 10 Analyst Ratings

Analysts' Consensus Price Target

$13.40
76.08% Upside

High Forecast	$18.00
Average Forecast	$13.40
Low Forecast	$8.00

Type	Current Forecast 12/2/22 to 12/2/23	1 Month Ago 11/2/22 to 11/2/23	3 Months Ago 9/3/22 to 9/3/23	1 Year Ago 12/2/21 to 12/2/22
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	5 Buy rating(s)	5 Buy rating(s)	6 Buy rating(s)	7 Buy rating(s)
Hold	5 Hold rating(s)	5 Hold rating(s)	6 Hold rating(s)	6 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$13.40	$13.75	$14.55	$17.36
Predicted Upside	76.08% Upside	35.01% Upside	26.09% Upside	25.88% Upside

Get Health Catalyst Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.

HCAT Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

HCAT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Health Catalyst Stock vs. The Competition

Type	Health Catalyst	Medical Companies	S&P 500
Consensus Rating Score	2.50	2.67	2.49
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	76.08% Upside	759.49% Upside	2,867.38% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
11/13/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$12.00 ➝ $11.00	+63.93%
11/1/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Hold ➝ Hold	$15.00 ➝ $12.00	+65.52%
10/30/2023	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Sector Perform ➝ Sector Perform	$13.00 ➝ $8.00	+12.68%
10/11/2023	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target		$14.00 ➝ $10.00	+1.52%
9/14/2023	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$16.00	+42.48%
8/29/2023	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$16.00 ➝ $14.00	+21.85%
5/10/2023	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
5/10/2023	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
4/11/2023	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Equal Weight	$13.00	+0.54%
4/4/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$13.00 ➝ $16.00	+34.79%
3/24/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy	$17.00 ➝ $16.00	+34.45%

(Data available from 12/2/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

HCAT Price Target - Frequently Asked Questions

What is Health Catalyst's consensus rating and price target?: According to the issued ratings of 10 analysts in the last year, the consensus rating for Health Catalyst stock is Moderate Buy based on the current 5 hold ratings and 5 buy ratings for HCAT. The average twelve-month price prediction for Health Catalyst is $13.40 with a high price target of $18.00 and a low price target of $8.00. Learn more on HCAT's analyst rating history.
Do Wall Street analysts like Health Catalyst more than its competitors?: Analysts like Health Catalyst less than other Medical companies. The consensus rating score for Health Catalyst is 2.50 while the average consensus rating score for medical companies is 2.67. Learn more on how HCAT compares to other companies.
Is Health Catalyst being upgraded by Wall Street analysts?: Over the previous 90 days, Health Catalyst's stock had 1 upgrade by analysts.

Does Health Catalyst's stock price have much upside?: According to analysts, Health Catalyst's stock has a predicted upside of 30.29% based on their 12-month stock forecasts.
What analysts cover Health Catalyst?: Health Catalyst has been rated by Cantor Fitzgerald, Evercore ISI, Piper Sandler, Royal Bank of Canada, and Stifel Nicolaus in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NASDAQ:HCAT) was last updated on 12/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial